FDA menthol ban would benefit Black, younger Americans
The U.S. Food and Drug Administration’s proposed ban on menthol flavored cigarettes and all flavored cigars could be particularly beneficial for Black and young people, says an expert on tobacco control at Washington University in St. Louis.
Elson elected to National Academy of Sciences
Elliot Elson, of Washington University School of Medicine, has been elected to the National Academy of Sciences. Election to the academy is considered one of the highest honors that can be awarded to a U.S. scientist or engineer.
Limbrick appointed to St. Louis Regional Health Commission
David D. Limbrick, MD, PhD, the T. S. Park, MD, Professor of Pediatric Neurosurgery at the School of Medicine, has been appointed to the St. Louis Regional Health Commission as the representative from the School of Medicine.
Draining brain’s debris enhances Alzheimer’s therapies in mice
New research in mice has shown that some investigational Alzheimer’s therapies are more effective when paired with a treatment geared toward improving drainage of fluid and debris from the brain, according to a study led by researchers at Washington University School of Medicine.
Stroke-recovery device using brain-computer interface receives FDA market authorization
A first-of-its kind device that helps people disabled by stroke regain significant control over their arm and hand function by using their minds has received market authorization from the Food and Drug Administration. The system developed by Neurolutions Inc., a WashU startup, relied on innovative multidisciplinary research at the university.
Researchers to study impact of IBD meds on COVID vaccine
The School of Medicine received a $1.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to support the work of Parakkal Deepak, MBBS, and Alfred H.J. Kim, MD, PhD. They will study antibody responses after vaccination against SARS-CoV-2 in patients with inflammatory bowel disease and other autoimmune diseases.
Anti-aging compound that improves metabolic health in mice improves muscle glucose metabolism in people
In the first clinical trial of nicotinamide mononucleotide (NMN), School of Medicine researchers have found that the compound previously demonstrated to counteract aspects of aging and improve metabolic health in mice also has clinically relevant effects in people.
Among COVID-19 survivors, an increased risk of death, serious illness
A new study from the School of Medicine shows that even mild cases of COVID-19 increase the risk of death in the six months following diagnosis. The comprehensive study also catalogues the wide-ranging and long-term health problems often triggered by the infection, even among those not hospitalized.
Feldman, Khader, Philips elected to American Academy of Microbiology
Three researchers at Washington University School of Medicine have been elected to the American Academy of Microbiology in recognition of their scientific achievements and original contributions that have advanced the field of microbiology.
Personalized cancer vaccines for breast, pancreatic cancers show promise
Researchers at Washington University School of Medicine have shown that personalized cancer vaccines made using DNA can program the immune system to attack malignant tumors, including breast and pancreatic cancers.
Older Stories